Controlling hamster cells, the workhorse of the biopharmaceutical industry

by Ricardo Valdés-Bango Curell, PhD student at the Dublin City University (Dublin PubhD, November 2018) Hamster Cells are key for the biopharmaceutical industry as they can be grown in a bioreactor to produce biopharmaceutical drugs. Those cells can be genetically modified to enhance their productive characteristics thus potentially lowering the cost of manufacturing advanced drugs. Chinese […]